Tim Kirchmann

Responsible for aligning pipeline development programs with the market access requirements of the AMNOG process, coordinating communications with HTA committees and supporting pricing strategy development.

Development of the early market access strategies for pipeline assets as part of the cross-functional teams and coordination of the communication with HTA bodies as well as support of the pricing strategy development.

Strategic and operational support of pharmaceutical companies in pricing and reimbursement processes in the context of market access for innovative pharmaceuticals. Focused on market access projects for orphan and non-orphan drugs as part of the early benefit assessment acc. to §35a SGB V (AMNOG) for > 20 leading pharmaceutical companies.

Banken und Finanzierung, Produktionswirtschaft